The way the healthcare industry thinks about interoperability doesn’t capture the whole story.
Interoperability is often described as ensuring that the right participants can access the right patient information at the right time, but that view encapsulates only part of its value. One way access is necessary, but it is not nearly sufficient.
True value emerges when retrieved data actively informs care and the resulting outcomes are fed back into the ecosystem as high-quality, traceable information that can be integrated into clinical and administrative workflows to improve health outcomes.
Shareback is not only a best practice, but also the fundamental mechanism that determines whether interoperability functions as a limited,extractive system or a reciprocal Learning Health System.
Will policymakers and network operators treat shareback quality as a core success metric, or will shareback remain an aspirational concept embedded loosely in participation agreements?
Until then, interoperability engine lacks the fuel to win the race for better patient care.
Why shareback matters
In recent years in healthcare, the predominant narrative around interoperability has focused on access.
While data access is certainly an important component of interoperability, data usability is equally critical, and that’s where shareback enters the picture. Absent a robust and consistent mechanism for share back, interoperability becomes a one-way transaction rather than a feedback loop.
Rather than merely focusing on data retrieval, a Learning Health System must measure, document, and share the results of using that data.
Most obligations and governance language around shareback concentrate on whether a response occurs at all, meaning whether a participant technically answered a query. While that perspective is necessary, it is not sufficient to drive meaningful value. Measuring the existence of a response is not the same as measuring its impact.
A high-volume stream of unstructured PDFs that cannot be reconciled, normalized, or embedded into clinical workflows offers little practical benefit. A response may exist, but a raw data dump rarely improves patient care.
Greater value comes from a smaller set of high-quality shareback artifacts that are closely tied to clinical decisions and patient outcomes, enabling controlled, intelligent feedback that supports measurable improvement.
5 traits of high-quality shareback
- Clinical relevance: Delivers information that directly supports decision-making and ongoing care.
- Provenance: Clearly identifies the requesting and source organizations, along with the clinical context of the exchange.
- Structure and standards alignment: Leverages structured formats that align with modern interoperability standards and workflows whenever feasible.
- Contextual linkage: Maintains a clear connection to the original retrieval event and the associated data set.
- Machine readability: Enables automated processing by EHRs, analytics platforms, AI tools, and quality reporting systems without manual data entry.
However, measuring whether shareback happens at all is insufficient for building a Learning Health System. The more important question is how effectively shareback contributes to better-informed care and improved outcomes.
If interoperability is intended to improve care, then shareback is the mechanism by which that improvement becomes visible and verifiable.
The role of intermediaries in shareback
Intermediaries such as Qualified Health Information Networks (QHINs), gateway vendors, and aggregators are essential to health data exchange, providing interface normalization, security, auditing, routing, and connectivity across diverse participants.
At the same time, their involvement introduces ambiguity around shareback responsibilities because intermediaries do not deliver care or generate the clinical outcomes that would be shared back, and regulatory frameworks generally place that obligation on provider organizations rather than on the intermediaries themselves.
This creates a structural tension in which intermediaries are well-positioned to support and enforce technical aspects of shareback but lack legal ownership of the obligation or the data.
Addressing this challenge requires clearer role definitions among providers, intermediaries, and governance bodies, explicit shareback requirements in participation agreements, and metrics that distinguish technical routing performance from the clinical effectiveness of shareback. Without this clarity, disputes over reciprocity are inevitable, particularly in Treatment-purpose networks built on the assumption that participants both access and contribute data.
Interoperability’s next step
Healthcare interoperability has largely solved the technical problem of enabling access to clinical data for treatment. Systems can now connect, data can flow across organizations, and longitudinal patient records can be assembled.The unresolved question is whether this exchange can be demonstrably tied to improvement. Shareback bridges the gap between access and improvement by turning interoperability from a compliance exercise into a driver of progress and by providing measurable proof that data exchange leads to better outcomes. It also reframes accountability. If an organization retrieves external data to inform care and generates new clinically relevant information, withholding that information may undermine the very reciprocity on which national networks are built.
The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable.
When shareback becomes a foundational expectation of interoperability, the care loop is closed, enabling complete, trusted data to support better decisions, more effective care coordination, and ultimately improved patient outcomes.
Photo: LeoWolfert, Getty Images
Patrick J. Laneis President and Chief Operating Officer of Health Gorilla, where he leads enterprise operations and strategy for one of the nation’s designated QHINs. With more than 25 years of experience, he has built and scaled technology businesses across healthcare and other regulated industries, driving disciplined growth, operational transformation, and long-term value creation.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
